Cited by 312Influenza Virus Research StudiesImmune responses and vaccinationsRespiratory viral infections research

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies

Open access

Sasaki, Sanae, Sullivan, Meghan, Narvaez, Carlos F., Holmes, Tyson H., Furman, David, Zheng, Nai-Ying, Nishtala, Madhuri, Wrammert, Jens, Smith, Kenneth, James, Judith A., Dekker, Cornelia L., Davis, Mark M., Wilson, Patrick C., Greenberg, Harry B., He, Xiao-Song·2011·Journal of Clinical Investigation

DOI 10.1172/jci57834PMC PMC3148747

Open this paper in CoChat — free account Open PDF

Abstract

During seasonal influenza epidemics, disease burden is shouldered predominantly by the very young and the elderly. Elderly individuals are particularly affected, in part because vaccine efficacy wanes with age. This has been linked to a reduced ability to induce a robust serum antibody response. Here, we show that this is due to reduced quantities of vaccine-specific antibodies, rather than a lack of antibody avidity or affinity. We measured levels of vaccine-specific plasmablasts by ELISPOT 1 week after immunization of young and elderly adults with inactivated seasonal influenza vaccine. Plasmablast-derived polyclonal antibodies (PPAbs) were generated from bulk-cultured B cells, while recombinant monoclonal antibodies (re-mAbs) were produced from single plasmablasts. The frequency of vaccine-specific plasmablasts and the concentration of PPAbs were lower in the elderly than in young adults, whereas the yields of secreted IgG per plasmablast were not different. Differences were not detected in the overall vaccine-specific avidity or affinity of PPAbs and re-mAbs between the 2 age groups. In contrast, reactivity of the antibodies induced by the inactivated seasonal influenza vaccine toward the 2009 pandemic H1N1 virus, which was not present in the vaccine, was higher in the elderly than in the young. These results indicate that the inferior antibody response to influenza vaccination in the elderly is primarily due to reduced quantities of vaccine-specific antibodies. They also suggest that exposure history affects the cross-reactivity of vaccination-induced antibodies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci57834

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006
A class of distributions which includes the normal ones
Azzalini, A. (1985) · Padua Research Archive (University of Padova) · Cited by 2,612
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,088
Centers for Disease Control and Prevention (CDC) : Advisory Committee on Immunization Practices (ACIP) : Quadrivalent human papillomavirus vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Le, M. (2007) · Medical Entomology and Zoology · Cited by 1,624
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · Cited by 1,302
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus
Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906453 · Cited by 1,260

Show all 52 references

Research works printed but not linked: 4

Fiore, 2007, MMWR Recomm Rep., 56, 1
Gerhard, 2001, Curr Top Microbiol Immunol., 260, 171
Azzalini, 1985, Scand J Statist., 12, 171
Holm, 1979, Scand J Statist., 6, 65

Sorted by citations

Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
Emerging concepts in the science of vaccine adjuvants
Pulendran, B., Arunachalam, P. S., & O’Hagan, D. T. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00163-y · Cited by 1,446
Vaccine adjuvants: mechanisms and platforms
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01557-7 · Cited by 1,020
Self-citation
Understanding immunosenescence to improve responses to vaccines
Goronzy, J. J., & Weyand, C. M. (2013) · Nature Immunology · doi:10.1038/ni.2588 · Cited by 827
Causes, consequences, and reversal of immune system aging
Montecino-Rodriguez, E., Berent-Maoz, B., & Dorshkind, K. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64096 · Cited by 793
Immunosenescence and human vaccine immune responses
Crooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0164-9 · Cited by 530
Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination
Müller, L., Andrée, M., Moskorz, W., Drexler, I., Walotka, L., Grothmann, R., Ptok, J., Hillebrandt, J., Ritchie, A., Rabl, D., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab381 · Cited by 511
The aging lung: Physiology, disease, and immunity
Schneider, J. L., Rowe, J. H., Garcia-de-Alba, C., Kim, C. F., Sharpe, A. H., & Haigis, M. C. (2021) · Cell · doi:10.1016/j.cell.2021.03.005 · Cited by 500
The immune system and aging: A review
Castelo-Branco, C., & Soveral, I. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2013.852531 · Cited by 449
Lineage Structure of the Human Antibody Repertoire in Response to Influenza Vaccination
Jiang, N., He, J., Weinstein, J. A., Penland, L., Sasaki, S., He, X.-S., Dekker, C. L., Zheng, N.-Y., Huang, M., Sullivan, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004794 · Cited by 335
Self-citation
Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures
Nakaya, H. I., Hagan, T., Duraisingham, S. S., Lee, E. K., Kwissa, M., Rouphael, N., Frasca, D., Gersten, M., Mehta, A. K., Gaujoux, R., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.11.012 · Cited by 337
In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire
DeKosky, B. J., Kojima, T., Rodin, A., Charab, W., Ippolito, G. C., Ellington, A. D., & Georgiou, G. (2014) · Nature Medicine · doi:10.1038/nm.3743 · Cited by 358
Sex, the aging immune system, and chronic disease
Bupp, M. G. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.02.002 · Cited by 333
Metabolic Phenotypes of Response to Vaccination in Humans
Li, S., Sullivan, N., Rouphael, N., Yu, T., Banton, S., Maddur, M. S., McCausland, M. M., Chiu, C., Canniff, J. D., Dubey, S. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.026 · Cited by 277
Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence
Lang, P. O., Mendès, Socquet, Assir, Govind, & Aspinall, R. (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s25215 · Cited by 242
The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines
McElhaney, J. E., Zhou, X., Talbot, H. K., Soethout, E., Bleackley, R. C., Granville, D. J., & Pawelec, G. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.015 · Cited by 229
B Cell Immunosenescence
Frasca, D., Diaz, A., Romero, M., Garcia, D., & Blomberg, B. B. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-011620-034148 · Cited by 232
Towards a universal influenza vaccine: different approaches for one goal
Sautto, G. A., Kirchenbaum, G. A., & Ross, T. M. (2018) · Virology Journal · doi:10.1186/s12985-017-0918-y · Cited by 202
Apoptosis and other immune biomarkers predict influenza vaccine responsiveness
Furman, D., Jojic, V., Kidd, B., Shen‐Orr, S., Price, J., Jarrell, J., Tse, T., Huang, H., Lund, P., Maecker, H. T., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.15 · Cited by 184
Self-citation
Effects of Aging, Cytomegalovirus Infection, and EBV Infection on Human B Cell Repertoires
Wang, C., Liu, Y., Xu, L. T., Jackson, K., Roskin, K. M., Pham, T. D., Laserson, J., Marshall, E. L., Seo, K., Lee, J.-Y., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301384 · Cited by 179
Self-citation
Origin and Function of Circulating Plasmablasts during Acute Viral Infections
Fink, K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00078 · Cited by 181
Circulating CXCR5+PD-1+ Response Predicts Influenza Vaccine Antibody Responses in Young Adults but not Elderly Adults
Herati, R. S., Reuter, M. A., Dolfi, D. V., Mansfield, K. D., Aung, H., Badwan, O. Z., Kurupati, R. K., Kannan, S., Ertl, H., Schmader, K. E., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302503 · Cited by 177
B cell maintenance and function in aging
Kogut, I., Scholz, J. L., Cancro, M. P., & Cambier, J. C. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.04.004 · Cited by 166
Immunosenescence and HIV
Deeks, S. G., Verdin, E. M., & McCune, J. M. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.05.004 · Cited by 169
Understanding immunosenescence and its impact on vaccination of older adults
Allen, J. C., Toapanta, F. R., Chen, W. H., & Tennant, S. M. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.11.002 · Cited by 161
Sex and Gender Impact Immune Responses to Vaccines Among the Elderly
Fink, A. L., & Klein, S. L. (2015) · Physiology · doi:10.1152/physiol.00035.2015 · Cited by 157
Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals
Henry, C., Zheng, N., Huang, M., Cabanov, A., Rojas, K. T., Kaur, K., Andrews, S. F., Palm, A.-K. E., Chen, Y.-Q., Li, Y., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.002 · Cited by 142
Self-citation
Tools to therapeutically harness the human antibody response
Wilson, P. C., & Andrews, S. F. (2012) · Nature reviews. Immunology · doi:10.1038/nri3285 · Cited by 149
Self-citation
The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations
Frasca, D., Diaz, A., Romero, M., & Blomberg, B. B. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.04.023 · Cited by 144
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
Ludwig, H., Boccadoro, M., Moreau, P., Miguel, J. F. S., Cavo, M., Pawlyn, C., Zweegman, S., Facon, T. T. F., Driessen, C., Hájek, R., et al. (2020) · Leukemia · doi:10.1038/s41375-020-01016-0 · Cited by 142
Defective TFH Cell Function and Increased TFR Cells Contribute to Defective Antibody Production in Aging
Sage, P. T., Tan, C. L., Freeman, G. J., Haigis, M. C., & Sharpe, A. H. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.015 · Cited by 145
Inactivated influenza vaccines
Fiore, A. E., Bridges, C. B., Katz, J. M., & Cox, N. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00026-4 · Cited by 135
Aging and influenza vaccine-induced immunity
Dugan, H. L., Henry, C., & Wilson, P. C. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.103998 · Cited by 137
Self-citation
The gracefully aging immune system
Boraschi, D., Aguado, M. T., Dutel, C., Goronzy, J., Louis, J., Grubeck-Loebenstein, B., Rappuoli, R., & Del Giudice, G. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005624 · Cited by 113
Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination
Frasca, D., & Blomberg, B. B. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00210-z · Cited by 130
Systems vaccinology: Enabling rational vaccine design with systems biological approaches
Hagan, T., Nakaya, H. I., Subramaniam, S., & Pulendran, B. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.072 · Cited by 131
Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs
Dhakal, S., & Klein, S. L. (2019) · Journal of Virology · doi:10.1128/jvi.00797-19 · Cited by 127
The current challenges for vaccine development
Oyston, P. C. F., & Robinson, K. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.039180-0 · Cited by 119
The confounded effects of age and exposure history in response to influenza vaccination
Mosterín, A., McElhaney, J. E., Fonville, J. M., Powers, D. C., BEYER, W. E. P., & Smith, D. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.11.058 · Cited by 112
Human B-1 Cells and B-1 Cell Antibodies Change With Advancing Age
Rodríguez‐Zhurbenko, N., Quách, T. D., Hopkins, T. J., Rothstein, T. L., & Hernández, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00483 · Cited by 111
A comparative review of aging and B cell function in mice and humans
Scholz, J. L., Diaz, A., Riley, R. L., Cancro, M. P., & Frasca, D. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.07.006 · Cited by 103
Immunosenescence and Novel Vaccination Strategies for the Elderly
Dorrington, M. G., & Bowdish, D. M. E. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00171 · Cited by 104
Cell culture-based influenza vaccines: A necessary and indispensable investment for the future
Hegde, N. R. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1016666 · Cited by 103
Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial
Dunning, A. J., DiazGranados, C. A., Voloshen, T., Hu, B. T., Landolfi, V. A., & Talbot, H. K. (2016) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00604-15 · Cited by 101
High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination
Tan, Y., Blum, L. K., Kongpachith, S., Ju, C., Cai, X., Lindström, T. M., Sokolove, J. B., & Robinson, W. H. (2014) · Clinical Immunology · doi:10.1016/j.clim.2013.12.008 · Cited by 103
Age-Related Changes in Human Peripheral Blood IGH Repertoire Following Vaccination
Wu, Y.-C. B., Kipling, D., & Dunn‐Walters, D. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00193 · Cited by 101
Plasma cell numbers decrease in bone marrow of old patients
Pritz, T., Lair, J., Ban, M., Keller, M., Weinberger, B., Krismer, M., & Grubeck‐Loebenstein, B. (2015) · European Journal of Immunology · doi:10.1002/eji.201444878 · Cited by 98
Factors affecting immune responses to the influenza vaccine
Castrucci, M. R. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1338547 · Cited by 98
Autophagy and Immune Senescence
Zhang, H., Puleston, D. J., & Simon, A. K. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.06.001 · Cited by 95
Amantadine and rimantadine for influenza A in children and the elderly
Galvão, M. G. A., Santos, M. A. R. C., & da Cunha, A. J. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002745.pub2 · Cited by 91
Age Affects Quantity but Not Quality of Antibody Responses after Vaccination with an Inactivated Flavivirus Vaccine against Tick-Borne Encephalitis
Stiasny, K., Aberle, J. H., Keller, M., Grubeck‐Loebenstein, B., & Heinz, F. X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034145 · Cited by 88
Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine
Frasca, D., Diaz, A., Romero, M., Phillips, M., Mendez, N. V., Landin, A. M., & Blomberg, B. B. (2012) · International Immunology · doi:10.1093/intimm/dxr123 · Cited by 86
Priming by a novel universal influenza vaccine (Multimeric-001)—A gateway for improving immune response in the elderly population
Atsmon, J., Caraco, Y., Ziv-Sefer, S., Shaikevich, D., Abramov, E., Volokhov, I., Bruzil, S., Haima, K. Y., Gottlieb, T. M., & Ben-Yedidia, T. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.031 · Cited by 88
AID Activity in B Cells Strongly Correlates with Polyclonal Antibody Affinity Maturation in-vivo Following Pandemic 2009-H1N1 Vaccination in Humans
Khurana, S., Frasca, D., Blomberg, B., & Golding, H. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002920 · Cited by 85
Aging, Cancer and Immunity
Hong, H., Wang, Q., Li, J., Liu, H. B., Meng, X., & Zhang, H. (2019) · Journal of Cancer · doi:10.7150/jca.30723 · Cited by 89
Immunosenescence and vaccine failure in the elderly: strategies for improving response
Boraschi, D., & Italiani, P. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.06.006 · Cited by 86
Telomere length as an indicator of the robustness of B- and T-cell response to influenza in older adults
Najarro, K., Nguyen, H., Chen, G., Xu, M., Alcorta, S., Yao, X., Zukley, L., Metter, E. J., Truong, T., Lin, Y., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv202 · Cited by 83
A systems biology approach to the effect of aging, immunosenescence and vaccine response
Poland, G. A., Ovsyannikova, I. G., Kennedy, R. B., Lambert, N. D., & Kirkland, J. L. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.04.005 · Cited by 85
Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains
Nuñez, I. A., Carlock, M. A., Allen, J. D., Owino, S. O., Geffel, K. M., Nowalk, M. P., Susick, M., Diagle, K., Sweeney, K., Mundle, S. T., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185666 · Cited by 85
Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes
Feng, E., Balint, E., Poznanski, S. M., Ashkar, A. A., & Loeb, M. B. (2021) · Cells · doi:10.3390/cells10030708 · Cited by 95
High Titer and Avidity of Nonneutralizing Antibodies against Influenza Vaccine Antigen Are Associated with Severe Influenza
To, K. K., Zhang, J., Hung, I. F., Xu, T., Ip, W. C., Wong, R. T. Y., Ng, J. C. K., Chan, J. F., Chan, K., & Yuen, K. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00081-12 · Cited by 83
Immunobiology of Influenza Vaccines
Lorenzo, M. M. G., & Fenton, M. J. (2013) · CHEST Journal · doi:10.1378/chest.12-1711 · Cited by 83
Host Resistance and Immune Aging
Bandaranayake, T., & Shaw, A. C. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.02.007 · Cited by 88
Age is the work of art? Impact of neutrophil and organism age on neutrophil extracellular trap formation
Ortmann, W., & Kolaczkowska, E. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2751-4 · Cited by 80
Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection
Merani, S., Pawelec, G., Kuchel, G. A., & McElhaney, J. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00784 · Cited by 74
Double-blind randomised controlled trial of vitamin D3supplementation for the prevention of acute respiratory infection in older adults and their carers (ViDiFlu)
Martineau, A. R., Hanifa, Y., Witt, K. D., Barnes, N. C., Hooper, R., Patel, M., Stevens, N. J., Enayat, Z. E., Balayah, Z., Syed, A., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-206996 · Cited by 80
Human adaptive immune receptor repertoire analysis—Past, present, and future
Nielsen, S. C. A., & Boyd, S. D. (2018) · Immunological Reviews · doi:10.1111/imr.12667 · Cited by 80
Immune responses to influenza virus and its correlation to age and inherited factors
Bahadoran, A., Lee, S. H., Wang, S. M., Manikam, R., Rajarajeswaran, J., Raju, C. S., & Sekaran, S. D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01841 · Cited by 79
Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination
Stebegg, M., Bignon, A., Hill, D. L., Silva-Cayetano, A., Krueger, C., Vanderleyden, I., Innocentin, S., Boon, L., Wang, J., Zand, M. S., et al. (2020) · eLife · doi:10.7554/elife.52473 · Cited by 77
The ocular surface immune system through the eyes of aging
Galletti, J. G., & de Paiva, C. S. (2021) · The Ocular Surface · doi:10.1016/j.jtos.2021.02.007 · Cited by 78
The Impact of Immunosenescence on Humoral Immune Response Variation after Influenza A/H1N1 Vaccination in Older Subjects
Haralambieva, I. H., Painter, S. D., Kennedy, R. B., Ovsyannikova, I. G., Lambert, N. D., Goergen, K. M., Oberg, A. L., & Poland, G. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122282 · Cited by 76
Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma
Avivi, I. M., Balaban, R., Shragai, T., Sheffer, G., Morales, M., Aharon, A., Lowenton‐Spier, N., Trestman, S., Perry, C., Benyamini, N., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17608 · Cited by 74
Mechanisms underpinning poor antibody responses to vaccines in ageing
Lee, J. L., & Linterman, M. A. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.11.001 · Cited by 73
Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination
Abreu, R. B., Kirchenbaum, G. A., Clutter, E. F., Sautto, G. A., & Ross, T. M. (2019) · JCI Insight · doi:10.1172/jci.insight.132155 · Cited by 71
Triggering Intracellular Receptors for Vaccine Adjuvantation
Gutjahr, A., Tiraby, G., Pérouzel, É., Verrier, B., & Paul, S. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.07.001 · Cited by 73
How T follicular helper cells and the germinal centre response change with age
Linterman, M. A. (2014) · Immunology & Cell Biology · doi:10.1038/icb.2013.77 · Cited by 69
Imprinting, immunodominance, and other impediments to generating broad influenza immunity
Knight, M., Changrob, S., Li, L., & Wilson, P. C. (2020) · Immunological Reviews · doi:10.1111/imr.12900 · Cited by 69
Self-citation
Immune Response Following H1N1pdm09 Vaccination: Differences in Antibody Repertoire and Avidity in Young Adults and Elderly Populations Stratified by Age and Gender
Khurana, S., Verma, N., Talaat, K. R., Karron, R. A., & Golding, H. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir791 · Cited by 67
B Cell Responses to Influenza Infection and Vaccination
Chiu, C., Ellebedy, A. H., Wrammert, J., & Ahmed, R. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_425 · Cited by 64
Self-citation
Immunosenescence, Aging, and Systemic Lupus Erythematous
Montoya-Ortiz, G. (2013) · Autoimmune Diseases · doi:10.1155/2013/267078 · Cited by 70
Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion
Pilkinton, M. A., Nicholas, K. J., Warren, C. M., Smith, R. M., Yoder, S. M., Talbot, H. K., & Kalams, S. A. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.059 · Cited by 65
Human lymphocyte repertoires in ageing
Boyd, S. D., Liu, Y., Wang, C., Martin, V., & Dunn‐Walters, D. K. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.07.007 · Cited by 61
B Cell Response and Hemagglutinin Stalk-Reactive Antibody Production in Different Age Cohorts following 2009 H1N1 Influenza Virus Vaccination
Sangster, M. Y., Baer, J., Santiago, F. W., Fitzgerald, T. F., Ilyushina, N. A., Sundararajan, A., Henn, A. D., Krammer, F., Yang, H., Luke, C. J., et al. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00735-12 · Cited by 59
Influenza Virus H1N1pdm09 Infections in the Young and Old: Evidence of Greater Antibody Diversity and Affinity for the Hemagglutinin Globular Head Domain (HA1 Domain) in the Elderly than in Young Adults and Children
Verma, N., Dimitrova, M., Carter, D. M., Crevar, C. J., Ross, T. M., Golding, H., & Khurana, S. (2012) · Journal of Virology · doi:10.1128/jvi.07085-11 · Cited by 60
B cell function and influenza vaccine responses in healthy aging and disease
Frasca, D., & Blomberg, B. B. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.05.008 · Cited by 60
The recent advances in vaccine adjuvants
Xing, J., Zhao, X., Li, X., Fang, R., Sun, M., Zhang, Y., & Song, N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1557415 · Cited by 67
The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?
Ward, B. J., Pillet, S., Charland, N., Trépanier, S., Couillard, J., & Landry, N. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1413518 · Cited by 61
Amantadine and rimantadine for influenza A in children and the elderly
Galvão, M. G. A., Santos, M. A. R. C., & da Cunha, A. J. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002745.pub4 · Cited by 62
Pregnancy Does Not Attenuate the Antibody or Plasmablast Response to Inactivated Influenza Vaccine
Kay, A. W., Bayless, N. L., Fukuyama, J., Aziz, N., Dekker, C. L., Mackey, S., Swan, G. E., Davis, M. M., & Blish, C. A. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv138 · Cited by 57
Self-citation
N-3 polyunsaturated fatty acids modulate B cell activity in pre-clinical models: Implications for the immune response to infections
Whelan, J. T., Gowdy, K. M., & Shaikh, S. R. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.100 · Cited by 56
Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience
Nicolay, U., Heijnen, E., Nacci, P., PATRIARCA, P. A., & Leav, B. A. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.03.026 · Cited by 59
Immune Senescence and Vaccination in the Elderly
Lang, P., Govind, S., ten Bokum, A. M. C., Kenny, N., Matas, E., Pitts, D., & Aspinall, R. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660181 · Cited by 33
Paradoxical aging in HIV: immune senescence of B Cells is most prominent in young age
Rinaldi, S., Pallikkuth, S., George, V. K., de Armas, L. R., Pahwa, R., Sanchez, C. M., Pallin, M., Pan, L., Cotugno, N., Dickinson, G. M., et al. (2017) · Aging · doi:10.18632/aging.101229 · Cited by 57
Aging and Options to Halt Declining Immunity to Virus Infections
Palacios-Pedrero, M. Á., Osterhaus, A. D. M. E., Becker, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.681449 · Cited by 55
Immune Defects in the Risk of Infection and Response to Vaccination in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
Tete, S. M., Bijl, M., Sahota, S., & Bos, N. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00257 · Cited by 56
Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness
Sanei, F., & Wilkinson, T. M. A. (2016) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465816646050 · Cited by 54
Immunotherapy in older patients with cancer
Granier, C., Gey, A., Roncelin, S., Weiss, L., Paillaud, É., & Tartour, É. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.07.009 · Cited by 58
Virus-Specific Antibody Secreting Cell, Memory B-cell, and Sero-Antibody Responses in the Human Influenza Challenge Model
Huang, K.-Y. A., Li, C. K., Clutterbuck, E., Chui, C., Wilkinson, T. M. A., Gilbert, A., OXFORD, J. S., Lambkin‐Williams, R., Lin, T., McMichael, A. J., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit650 · Cited by 52
Microbiota–host interactions shape ageing dynamics
Popkes, M., & Valenzano, D. R. (2020) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2019.0596 · Cited by 54
B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat
Guthmiller, J. J., Utset, H. A., & Wilson, P. C. (2021) · Viruses · doi:10.3390/v13060965 · Cited by 56
Self-citation

Authors: Sasaki, S., Sullivan, M., Narvaez, C. F., Holmes, T. H., Furman, D., Zheng, N.-Y., Nishtala, M., Wrammert, J., Smith, K., James, J. A., Dekker, C. L., Davis, M. M., Wilson, P. C., Greenberg, H. B., & He, X.-S.
Affiliations: Stanford Medicine (US)
University of Chicago (US)
Emory University (US)
Oklahoma Medical Research Foundation (US)
Stanford University (US)
ORCID: Holmes, Tyson H.
Furman, David
Zheng, Nai-Ying
Nishtala, Madhuri
Wrammert, Jens
James, Judith A.
Dekker, Cornelia L.
Davis, Mark M.
Wilson, Patrick C.
Greenberg, Harry B.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2011-08-01
Volume: 121
Issue: 8
Pages: 3109-3119
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci57834
PMC: PMC3148747
OpenAlex: W2105359173
Cited by: 300
References: 52
Citations by year: 2026: 14 · 2025: 13 · 2024: 8 · 2023: 21 · 2022: 18 · 2021: 33 · 2020: 15 · 2019: 26 · 2018: 15 · 2017: 22 · 2016: 18 · 2015: 20 · 2014: 19 · 2013: 27 · 2012: 25
FWCI: 18.32
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (AI090023, AI057266, AI057229, DK56339)
National Institute of Allergy and Infectious Diseases (AI 057229, AI057158, U19AI090023, U19AI090019, AI057266, HHSN266200500026C, AI090023, U54AI057158, U19AI057229, U19AI057266)
National Institute of Diabetes and Digestive and Kidney Diseases (DK-56339, P30DK056339)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR053483)
Topics: Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords: inactivated influenza vaccine, vaccine efficacy, older adults, plasmablasts, antibody avidity, antibody affinity, 2009 H1N1 pandemic, cross-reactivity, exposure history, B cells, monoclonal antibodies
MeSH terms: Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Antibodies, Antibodies, Monoclonal, Antibody Affinity, Enzyme-Linked Immunosorbent Assay, Humans, Immunoglobulin A, Immunoglobulin G, Influenza, Human, Influenza Vaccines, Plasma Cells, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks